Mariner Independent Advisor Network’s Zymeworks ZYME Stock Holding History

Mariner Independent Advisor Network’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.82M	Buy	+296,375	New	+$1.79M	0.08%	257

Other funds holding ZYME

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BNP Paribas Asset Management

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Mariner Independent Advisor Network's ZYME Position: Q3 2022 in Review

Mariner Independent Advisor Network opened a new position in Zymeworks (ZYME) in Q3 2022: 296,375 shares worth $1.82M. The stake represents 0.08% of the portfolio and ranks #257 among its holdings.

91 funds tracked by Wall St. Rank hold ZYME as of Q3 2022.

Mariner Independent Advisor Network held 296,375 shares of Zymeworks worth $1.82M as of Q3 2022.
Zymeworks was a new Mariner Independent Advisor Network position in Q3 2022.
Zymeworks made up 0.08% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #257 holding.
91 funds tracked by Wall St. Rank held Zymeworks as of Q3 2022.

Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.